参考文献/References:
[1] HARTZELL C,ARREOLA J. Calcium-activated chloride channels[J]. Annual review of physiology,2005,67(1):719-758.
[2]TWYFFELS L,STRICKAERT A,VIRREIRA M,et al. Anoctamin-1/TMEM16A is the major apical iodide channel of the thyrocyte[J]. American journal of physiology cell physiology,2014,307(12):1102-1112.
[3]ANTONELLA C,EMANUELA C,LORETTA F,et al. TMEM16A,a membrane protein associated with calcium-dependent chloride channel activity[J]. Science,2008,322(5901):590-594.
[4]SCHROEDER B C,CHENG T,JAN Y N,et al. Expression cloning of TMEM16A as a calcium-activated chloride channel subunit[J]. Cell,2008,134(6):1019-1029.
[5]YOUNG D Y,HAWON C,JAE Y K,et al. TMEM16A confers receptor-activated calcium-dependent chloride conductance[J]. Nature,2008,455(7217):1210-125.
[6]KUNZELMANN K,KONGSUPHOL P,ALDEHNI F,et al. Bestrophin and TMEM16—Ca activated Cl channels with different functions[J]. Cell calcium,2009,46(4):233-241.
[7]OH U,JUNG J. Cellular functions of TMEM16/anoctamin[J]. Pflügers archiv-European journal of physiology,2016,468(3):1-11.
[8]MAZZONE A,EISENMAN S T,STREGE P R,et al. Inhibition of cell proliferation by a selective inhibitor of the Ca2+-activated Cl-channel,Ano1[J]. Biochemical & biophysical research communications,2012,427(2):248-253.
[9]STANICH J E,GIBBONS S J,EISENMAN S T,et al. Ano1 as a regulator of proliferation[J]. American journal of physiology gastrointestinal & liver physiology,2011,301(6):G1044.
[10]UMAMAHESWAR D,SHIWARSKI D J,DONG X,et al. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression[J]. Cancer research,2012,72(13):3270-3781.
[11]BORIS M,AISTE T,PAOLO T. TMEM16A/anoctamin 1 protein mediates calcium-activated chloride currents in pulmonary arterial smooth muscle cells[J]. Journal of physiology,2010,588(13):2305-2314.
[12]DAYAL A,NG S F J,GRABNER M. Ca2+-activated Cl-channel TMEM16A/ANO1 identified in zebrafish skeletal muscle is crucial for action potential acceleration[J]. Nature communications,2019,10(1):1-15.
[13]RANDO A T. Primary mouse myoblast purification,characterization,and transplantation for cell-mediated gene therapy[J]. Journal of cell biology,1994,125(6):1275-1287.
[14]熊雷,何衍佶,戴威,等. 小鼠原代成肌细胞分离、纯化及培养[J]. 现代医药卫生,2017,33(3):23-25.
[15]ARTAZA J N,BHASIN S,MALLIDIS C,et al. Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells[J]. Journal of cellular physiology,2002,190(2):170-179.
[16]CHAL J,POURQUI O. Making muscle:skeletal myogenesis in vivo and in vitro[J]. Development,2017,144(12):2104.
[17]WAN N,PUAY W,VERKMAN A S. TMEM16A inhibitors reveal TMEM16A as a minor component of calcium-activated chloride channel conductance in airway and intestinal epithelial cells[J]. Journal of biological chemistry,2011,286(3):2365-2374.
[18]MONCAUT N,RIGBY P W,CARVAJAL J J. Dial M(RF)for myogenesis[J]. Febs journal,2013,280(17):3980-3890.
[19]NABESHIMA Y,HANAOKA K,HAYASAKA M,et al. Myogenin gene disruption results in perinatal lethality because of severe muscle defect[J]. Nature,1993,364(6437):532-535.
[20]WHITE M M,AYLWIN M. Niflumic and flufenamic acids are potent reversible blockers of Ca2+-activated Cl-channels in Xenopus oocytes[J]. Molecular pharmacology,1990,37(5):720-724.
[21]SAYO M,SATOMI N,KATSUHIKO M,et al. Downregulation of Ca2+-activated Cl- channel TMEM16A by the inhibition of histone deacetylase in TMEM16A-expressing cancer cells[J]. Journal of pharmacology & experimental therapeutics,2014,351(3):510-518.
[22]OTTOLIA M,TORO L. Potentiation of large conductance KCa channels by niflumic,flufenamic,and mefenamic acids[J]. Biophysical journal,1994,67(6):2272-2279.
[23]OH S J,HWANG S J,JUNG J,et al. MONNA,a potent and selective blocker for transmembrane protein with unknown function 16/anoctamin-1[J]. Molecular pharmacology,2013,84(5):726-735.
[24]BOEDTKJER D M B,KIM S,JENSEN A B,et al. New selective inhibitors of calcium-activated chloride channels-T16A(inh)-A01,CaCC(inh)-A01 and MONNA—what do they inhibit?[J]. British journal of pharmacology,2015,172(16):4158-4172.
[25]DAVIS A J,SHI J,PRITCHARD H A,et al. Potent vasorelaxant activity of the TMEM16A inhibitor T16A(inh)-A01[J]. British journal of pharmacol,2013,168(3):773-784.
[26]ADRIAN B,ANKE B,HEIKE B,et al. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling[J]. Proceedings of the national academy of sciences of the United States of America,2013,110(11):E1026-E1034.
[27]SONG Y,GAO J,GUAN L,et al. Inhibition of ANO1/TMEM16A induces apoptosis in human prostate carcinoma cells by activating TNF-α signaling[J]. Cell death & disease,2018,9(6):703.
[28]WEN L,MIN L,BAOGANG L,et al. Inhibition of Ca2+-activated Cl- channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma[J]. Cancer letters,2012,326(1):41-51.